KLK3 and metastatic malignant neoplasm in the lymph nodes: 32.1%, p = 0.027), more lymph node metastasis (65.4% vs. 42.0%, p = 0.038), more high-burden metastasis (EOD score ≥ 2) (96.2% vs. 29.6%, p < 0.001) and higher PSA level at diagnosis (758.55 [427.25–950.99] ng/mL vs. 131.75 [35.35–344.31] ng/mL, p < 0.001).